Journal
HEPATOLOGY INTERNATIONAL
Volume 13, Issue 2, Pages 113-124Publisher
SPRINGER
DOI: 10.1007/s12072-018-9912-8
Keywords
Adaptive immunity; CD4+T-lymphocytes; CD8+T-lymphocytes; Hepatitis B; Immunotherapy
Categories
Ask authors/readers for more resources
Chronic hepatitis B virus (HBV) infection is a major global health burden and cure is rarely achieved by current antiviral therapies. Therefore, there is an urgent need for new therapeutic options. Immune modulation with the goal to restore dysfunctional HBV-specific immunity is an interesting target for new therapeutic strategies. Based on the current evidence on immunology in resolving and persistent HBV infection, we will review the growing field of immunotherapeutic approaches for treatment of chronic HBV infection. We will also discuss the challenge of a heterogeneous patient population and personalized treatment as a possible key factor of success. [GRAPHICS]
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available